相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1
Laura Dickinson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component
Patricia M. Flynn et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
Na Yang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants
Rajendra P. Singh et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
Perrine Courlet et al.
JOURNAL OF MASS SPECTROMETRY (2020)
Low raltegravir transfer into the breastmilk of a woman living with HIV
Cornelia Feiterna-Sperling et al.
AIDS (2020)
Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV
E. M. Hodel et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)
Catriona Waitt et al.
PLOS MEDICINE (2019)
Bioequivalence of the Once-Daily Single-Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability
Herta M. Crauwels et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals
Rebecca Begley et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings
Catriona Waitt et al.
LANCET HIV (2018)
Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry
Perrine Courlet et al.
CLINICAL MASS SPECTROMETRY (2018)
Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide
Joseph M. Custodio et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir
Rajesh Krishna et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption
Kenneth K. Mugwanya et al.
PLOS MEDICINE (2016)
Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study
Adeniyi Olagunju et al.
CLINICAL INFECTIOUS DISEASES (2015)
Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies
Catriona John Waitt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial
Jose Molto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744
Susan L. Ford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients
Manel Aouri et al.
JOURNAL OF MASS SPECTROMETRY (2013)
The Brain Entry of HIV-1 Protease Inhibitors Is Facilitated When Used in Combination
Catia Marzolini et al.
MOLECULAR PHARMACEUTICS (2013)
Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants
Jessica M. Fogel et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Maternal antiretroviral prophylaxis and breastfeeding
Catia Marzolini et al.
ANTIVIRAL THERAPY (2012)
Modest but Variable Effect of Rifampin on Steady-State Plasma Pharmacokinetics of Efavirenz in Healthy African-American and Caucasian Volunteers
Awewura Kwara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis
Clement Zeh et al.
PLOS MEDICINE (2011)
Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
Larissa A. Wenning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine
A. Fayet et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review
C. L. Cooper et al.
HIV MEDICINE (2007)
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
JW Jonker et al.
NATURE MEDICINE (2005)
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers
JAH Droste et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Drug therapy: Drug therapy for breast-feeding women.
S Ito
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
